Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features.

Histology and histopathology - 1 Jun 2012

Martin V, Botta F, Zanellato E, Molinari F, Crippa S, Mazzucchelli L, Frattini M

Abstract excerpt

AIMS: Triple negative breast cancer with basal like features (TN-BCBL) do not benefit from hormonal and anti-HER2 therapies. As a considerable fraction of TN-BCBLs shows EGFR deregulation, EGFR-targeted therapies have been proposed as an option. The characterization of EGFR and EGFR-downstream members may therefore provide important predictive information. METHODS AND RESULTS: Based on morphological and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patient Selection

Share to Phosphatidylinositol 3-Kinases

Share to PTEN Phosphohydrolase

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 22473698
DOI: 10.14670/HH-27.785

Genes

EGFR
PTEN
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features.PMID 22473698Read ↗

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.Semantic proximity Read ↗

Triple-negative breast cancer: current state of the art.Semantic proximity Read ↗

[Basal-like breast cancers: clinicopathological features and outcome].Semantic proximity Read ↗

Characteristics of triple-negative breast cancer.Semantic proximity Read ↗

EGFR associated expression profiles vary with breast tumor subtypeSemantic proximity Read ↗

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cellsSemantic proximity Read ↗

Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohortSemantic proximity Read ↗

High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers.Semantic proximity Read ↗

[Identification of basal-like carcinomas in clinical practice: "triple zero/BRCA1-like" carcinomas].Semantic proximity Read ↗

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.Semantic proximity Read ↗

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.